Provided are an electroluminescent material and a device thereof. The electroluminescent material is a metal complex having a ligand represented by Formula 1 and can be used as light-emitting materials in electroluminescent devices. These new metal complexes can effectively regulate and control the luminescence wavelength, reduce the drive voltage of electroluminescent devices, greatly improve the current efficiency, power efficiency and EQE of electroluminescent devices, prolong the device lifetime, and provide better device performance. Further provided are an electroluminescent device and a compound composition.

Provided are an electroluminescent material and a device thereof. The electroluminescent material is a metal complex having a ligand represented by Formula 1 and can be used as light-emitting materials in electroluminescent devices. These new metal complexes can effectively regulate and control the luminescence wavelength, reduce the drive voltage of electroluminescent devices, greatly improve the current efficiency, power efficiency and EQE of electroluminescent devices, prolong the device lifetime, and provide better device performance. Further provided are an electroluminescent device and a compound composition.

To provide a method for producing an amidinate metal complex which is represented by [R.sup.1—N—C(R.sup.3)—N—R.sup.2]nM in cost saving and simple manner.

A method for producing an amidinate metal complex represented by [R.sup.1—N—C(R.sup.3)—N—R.sup.2]nM including: a first step in which R.sup.3X is reacted with a metal Li in a solvent to obtain R.sup.3Li solution with LiX suspended therein; a second step in which the R.sup.3Li solution with LiX existing therein is reacted with R.sup.1—N═C═N—R.sup.2 to obtain a [R.sup.1—N—C(R.sup.3)—N—R.sup.2]Li solution with the LiX suspended therein; a third step in which the [R.sup.1—N—C(R.sup.3)—N—R.sup.2]Li solution with the LiX existing therein is reacted with MX to obtain an amidinate metal complex solution, represented by the [R.sup.1—N—C(R.sup.3)—N—R.sup.2]nM, with the LiX suspended therein; and a fourth step for removing the LiX in the solution obtained by the third step.

Methods of synthesizing aminoiodosilanes are disclosed. The reaction to produce the disclosed aminoiodosilanes is represented by the formula:
SiI.sub.4+z(NH.sub.2R.sup.1)═SiI.sub.y(NHR.sup.1).sub.z,
wherein R.sup.1 is selected from a C.sub.1-C.sub.10 alkyl or cycloalkyl, aryl, or a hetero group; y=1 to 3; and z=4−y.

The present disclosure relates to a perovskite that includes ABX.sub.3, where A is an organic cation, B is a second cation, X is an anion, and the perovskite has a film density (ρ) of less than 4.37 g/cm.sup.3. In some embodiments of the present disclosure, the film density may be in the range, 4.1 g/cm.sup.3≤ρ≤4.37 g/cm.sup.3. In some embodiments of the present disclosure, the organic cation may include at least one of dimethylammonium (DMA), guanidinium (GA), and/or acetamidinium (Ac). In some embodiments of the present disclosure, A may further include cesium.

The invention provides a method comprising hydrogenating a ketone in the presence of (i) a base, (ii) hydrogen gas and (iii) a catalyst comprising a charged or neutral complex of formula (I):

##STR00001## wherein: Mn is a manganese atom or a manganese ion in oxidation state (I) to (VII); R.sup.1 and R.sup.2 are each independently optionally substituted C.sub.4-8monocyclic aryl or C.sub.3-7monocyclic heteroaryl moieties; -Fc- denotes a ferrocene (bis(η.sup.5-cyclopentadienyl)iron) moiety covalently bonded via adjacent carbon atoms of one of the two cyclopentadienyl moieties, and which may be optionally further substituted, in either cyclopentadienyl ring; —Z— is an alkylene linker of the formula —(CH.sub.2).sub.1-6— in which one or more of the hydrogen atoms of the alkylene may be independently substituted; —N.sup.x is an optionally substituted nitrogen-containing heteroaryl moiety, with the proviso that at least one of R.sup.1, R.sup.2 and —N.sup.x is substituted one or more times with an electron donating group; and L.sup.1-L.sup.3 constitute one, two or three ligands, wherein, when the complex of formula (I) is charged, the catalyst comprises one or more additional counterions to balance the charge of the complex.

A pyrazole metal complex for absorption of carbon dioxide, a method for preparing the pyrazole metal complex, and a method for absorbing carbon dioxide are provided; wherein the product produced by reacting pyrazole metal complex and carbon dioxide may be transformed into several economically valuable compounds.

The invention relates to an organic molecule for optoelectronic devices. According to the invention, the organic molecule has: —a first chemical moiety with a structure of formula (I), —two second chemical moieties with a structure of formula (II), wherein X and Y are at each occurrence independently from another selected from the group consisting of B and N; Z is a direct bond; R.sup.I, R.sup.II, R.sup.III, R.sup.IV, R.sup.V, R.sup.VI, R.sup.VII, R.sup.VIII, R.sup.IX, and R.sup.X are at each occurrence independently from another selected from the group consisting of the binding site of a single bond linking the first chemical moiety to the second moiety, and R*; R* is at each occurrence independently from another selected from the group consisting of hydrogen, deuterium, OPh, SPh, CF.sub.3, CN, F, Si(C.sub.1-C.sub.5-alkyl).sub.3, Si(Ph).sub.3, C.sub.1-C.sub.5-alkyl, C.sub.1-C.sub.5-alkoxy, C.sub.1-C.sub.5-thioalkoxy, C.sub.2-C.sub.5-alkenyl, C.sub.2-C.sub.5-alkynyl, C.sub.6-C.sub.18-aryl, C.sub.3-C.sub.17-heteroaryl, N(C.sub.6-C.sub.18-aryl).sub.2, N(C.sub.3-C.sub.17-heteroaryl).sub.2; N(C.sub.3-C.sub.17-heteroaryl)(C.sub.6-C.sub.18-aryl); and the dashed lines represent the binding sites of the first chemical moiety to the second chemical moiety.

##STR00001##

The invention relates to an organic molecule for optoelectronic devices. According to the invention, the organic molecule has: —a first chemical moiety with a structure of formula (I), —two second chemical moieties with a structure of formula (II), wherein X and Y are at each occurrence independently from another selected from the group consisting of B and N; Z is a direct bond; R.sup.I, R.sup.II, R.sup.III, R.sup.IV, R.sup.V, R.sup.VI, R.sup.VII, R.sup.VIII, R.sup.IX, and R.sup.X are at each occurrence independently from another selected from the group consisting of the binding site of a single bond linking the first chemical moiety to the second moiety, and R*; R* is at each occurrence independently from another selected from the group consisting of hydrogen, deuterium, OPh, SPh, CF.sub.3, CN, F, Si(C.sub.1-C.sub.5-alkyl).sub.3, Si(Ph).sub.3, C.sub.1-C.sub.5-alkyl, C.sub.1-C.sub.5-alkoxy, C.sub.1-C.sub.5-thioalkoxy, C.sub.2-C.sub.5-alkenyl, C.sub.2-C.sub.5-alkynyl, C.sub.6-C.sub.18-aryl, C.sub.3-C.sub.17-heteroaryl, N(C.sub.6-C.sub.18-aryl).sub.2, N(C.sub.3-C.sub.17-heteroaryl).sub.2; N(C.sub.3-C.sub.17-heteroaryl)(C.sub.6-C.sub.18-aryl); and the dashed lines represent the binding sites of the first chemical moiety to the second chemical moiety.

##STR00001##

A sensor (e.g., an optical sensor) that may be implanted within a living animal (e.g., a human) and may be used to measure an analyte (e.g., glucose or oxygen) in a medium (e.g., interstitial fluid, blood, or intraperitoneal fluid) within the animal. The sensor may include a sensor substrate, electrode or housing, an analyte indicator covering at least a portion of the sensor, and one or more compounds that reduce degradation of the analyte indicator.